000179134 001__ 179134
000179134 005__ 20240229145534.0
000179134 0247_ $$2doi$$a10.1186/s13073-022-01030-0
000179134 0247_ $$2pmid$$apmid:35287713
000179134 0247_ $$2altmetric$$aaltmetric:124652907
000179134 037__ $$aDKFZ-2022-00491
000179134 041__ $$aEnglish
000179134 082__ $$a610
000179134 1001_ $$0P:(DE-He78)b4004ee4b650b575447f59a4a0471312$$aSowah, Solomon$$b0$$eFirst author$$udkfz
000179134 245__ $$aCalorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial.
000179134 260__ $$aLondon$$bBioMed Central$$c2022
000179134 3367_ $$2DRIVER$$aarticle
000179134 3367_ $$2DataCite$$aOutput Types/Journal article
000179134 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1647511529_5965
000179134 3367_ $$2BibTeX$$aARTICLE
000179134 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000179134 3367_ $$00$$2EndNote$$aJournal Article
000179134 500__ $$a#EA:C020#LA:C020#
000179134 520__ $$aThe gut microbiota has been suggested to play a significant role in the development of overweight and obesity. However, the effects of calorie restriction on gut microbiota of overweight and obese adults, especially over longer durations, are largely unexplored.Here, we longitudinally analyzed the effects of intermittent calorie restriction (ICR) operationalized as the 5:2 diet versus continuous calorie restriction (CCR) on fecal microbiota of 147 overweight or obese adults in a 50-week parallel-arm randomized controlled trial, the HELENA Trial. The primary outcome of the trial was the differential effects of ICR versus CCR on gene expression in subcutaneous adipose tissue. Changes in the gut microbiome, which are the focus of this publication, were defined as exploratory endpoint of the trial. The trial comprised a 12-week intervention period, a 12-week maintenance period, and a final follow-up period of 26 weeks.Both diets resulted in ~5% weight loss. However, except for Lactobacillales being enriched after ICR, post-intervention microbiome composition did not significantly differ between groups. Overall weight loss was associated with significant metabolic improvements, but not with changes in the gut microbiome. Nonetheless, the abundance of the Dorea genus at baseline was moderately predictive of subsequent weight loss (AUROC of 0.74 for distinguishing the highest versus lowest weight loss quartiles). Despite the lack of consistent intervention effects on microbiome composition, significant study group-independent co-variation between gut bacterial families and metabolic biomarkers, anthropometric measures, and dietary composition was detectable. Our analysis in particular revealed associations between insulin sensitivity (HOMA-IR) and Akkermansiaceae, Christensenellaceae, and Tanerellaceae. It also suggests the possibility of a beneficial modulation of the latter two intestinal taxa by a diet high in vegetables and fiber, and low in processed meat.Overall, our results suggest that the gut microbiome remains stable and highly individual-specific under dietary calorie restriction.The trial, including the present microbiome component, was prospectively registered at ClinicalTrials.gov NCT02449148 on May 20, 2015.
000179134 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000179134 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000179134 650_7 $$2Other$$aGut microbiome
000179134 650_7 $$2Other$$aIntermittent calorie restriction
000179134 650_7 $$2Other$$aObesity
000179134 650_7 $$2Other$$aOverweight
000179134 650_7 $$2Other$$aWeight loss
000179134 7001_ $$aMilanese, Alessio$$b1
000179134 7001_ $$0P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aSchübel, Ruth$$b2
000179134 7001_ $$aWirbel, Jakob$$b3
000179134 7001_ $$aKartal, Ece$$b4
000179134 7001_ $$0P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aJohnson, Theron S$$b5$$udkfz
000179134 7001_ $$aHirche, Frank$$b6
000179134 7001_ $$0P:(DE-He78)9a183bfc8348c1db81a0ecf1458d0708$$aGrafetstätter, Mirja$$b7
000179134 7001_ $$aNonnenmacher, Tobias$$b8
000179134 7001_ $$aKirsten, Romy$$b9
000179134 7001_ $$aLópez-Nogueroles, Marina$$b10
000179134 7001_ $$aLahoz, Agustín$$b11
000179134 7001_ $$aSchwarz, Kathrin V$$b12
000179134 7001_ $$aOkun, Jürgen G$$b13
000179134 7001_ $$aUlrich, Cornelia M$$b14
000179134 7001_ $$aNattenmüller, Johanna$$b15
000179134 7001_ $$avon Eckardstein, Arnold$$b16
000179134 7001_ $$aMüller, Daniel$$b17
000179134 7001_ $$aStangl, Gabriele I$$b18
000179134 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b19$$udkfz
000179134 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b20$$eLast author
000179134 7001_ $$00000-0003-1429-7485$$aZeller, Georg$$b21
000179134 773__ $$0PERI:(DE-600)2484394-5$$a10.1186/s13073-022-01030-0$$gVol. 14, no. 1, p. 30$$n1$$p30$$tGenome medicine$$v14$$x1756-994X$$y2022
000179134 909CO $$ooai:inrepo02.dkfz.de:179134$$pVDB
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b4004ee4b650b575447f59a4a0471312$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ceb74219d144ab5760a228e71440c5ca$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9a183bfc8348c1db81a0ecf1458d0708$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000179134 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000179134 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000179134 9141_ $$y2022
000179134 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-02-03
000179134 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bGENOME MED : 2021$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-14T16:20:36Z
000179134 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-14T16:20:36Z
000179134 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-14T16:20:36Z
000179134 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-22
000179134 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bGENOME MED : 2021$$d2022-11-22
000179134 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000179134 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000179134 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000179134 980__ $$ajournal
000179134 980__ $$aVDB
000179134 980__ $$aI:(DE-He78)C020-20160331
000179134 980__ $$aUNRESTRICTED